CHRONIC LEUKAEMIA

This adverse event was reported 175 times

These drugs are most commonly taken by patients reporting CHRONIC LEUKAEMIA:

# Drug Count
0 PREGABALIN 10
1 GABAPENTIN 9
2 RUXOLITINIB 9
3 INTERFERON BETA-1A 8
4 ASPIRIN 7
5 APIXABAN 6
6 ASPIRIN 325 MG 6
7 ASPIRIN 81 MG 6
8 DENOSUMAB 6
9 ETANERCEPT 6
See all common drugs associated with CHRONIC LEUKAEMIA

CHRONIC LEUKAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE 1 0.0011
1 PIRTOBRUTINIB 1 0.0010
2 TOLNAFTATE 1 0.0008
3 RYDAPT 1 0.0005
4 DAPRODUSTAT 1 0.0005
5 AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL 1 0.0004
6 DANAZOL 1 0.0004
7 INFLIXIMAB-DYYB 1 0.0003
8 ASCIMINIB 1 0.0003
9 CARBIDOPA LEVODOPA 1 0.0003
See all drugs enriched for association with CHRONIC LEUKAEMIA

CHRONIC LEUKAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
1 Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] 1 0.0004
2 Thrombopoietin Receptor Agonist [EPC] 4 0.0003
3 Photoenhancer [EPC] 1 0.0003
4 Ergot Derivative [EPC] 1 0.0002
5 Nonergot Dopamine Agonist [EPC] 2 0.0001
6 Anti-anginal [EPC] 1 0.0001
7 Sulfone [EPC] 1 0.0001
8 BCL-2 Inhibitor [EPC] 5 0.0001
9 GLP-2 Analog [EPC] 1 0.0001
See all drug classes enriched for association with CHRONIC LEUKAEMIA